← FDA Drug Approvals (Drugs@FDA)

ERIBULIN MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHIA TAI TIANQING · Approved 2025-03-04

Drug application

FDA Application #

ANDA218743

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERIBULIN MESYLATE

Generic name

ERIBULIN MESYLATE

Active ingredients

ERIBULIN MESYLATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

CHIA TAI TIANQING

Manufacturer

Sun Pharmaceutical Industries Limited

First approval

2025-03-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown